Report overview
Botulinum toxin type A is a dilute solution of purified botulinum toxin that is used by injection for medical and cosmetic purposes (as to treat blepharospasm and spasmodic torticollis and to minimize wrinkles)
This report contains market size and forecasts of Botulinum Toxin Type A in global, including the following market information:
Global Botulinum Toxin Type A Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Botulinum Toxin Type A Market Sales, 2017-2022, 2023-2028, (L)
Global top five Botulinum Toxin Type A companies in 2021 (%)
The global Botulinum Toxin Type A market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50 Units Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Botulinum Toxin Type A include ALLERGAN, Galderma, Merz Pharma, DAEWOONG, Ipsen and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Botulinum Toxin Type A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Botulinum Toxin Type A Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Botulinum Toxin Type A Market Segment Percentages, by Type, 2021 (%)
50 Units
100 Units
200 Units
Global Botulinum Toxin Type A Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Botulinum Toxin Type A Market Segment Percentages, by Application, 2021 (%)
Cosmetic Applications
Therapeutic Applications
Others
Global Botulinum Toxin Type A Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Botulinum Toxin Type A Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Botulinum Toxin Type A revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Botulinum Toxin Type A revenues share in global market, 2021 (%)
Key companies Botulinum Toxin Type A sales in global market, 2017-2022 (Estimated), (L)
Key companies Botulinum Toxin Type A sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ALLERGAN
Galderma
Merz Pharma
DAEWOONG
Ipsen
Pfizer
